AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32179149 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LD and NLD)
Number of subjects: 20
Study 36343166 — intervention group
Group type: EXPERIMENTAL
Intervention: DMEK
Number of subjects: 56
Study 36343166 — intervention group
Group type: COMPARATOR
Intervention: MT-DSAEK
Number of subjects: 56
Study 34741629 — intervention group
Group type: EXPERIMENTAL
Intervention: Small IMN (10 mm in males, 9 mm in females)
Number of subjects: 60
Study 34741629 — intervention group
Group type: COMPARATOR
Intervention: Large IMN (12 mm in males, 11 mm in females)
Number of subjects: 60
Study 34187482 — intervention group
Group type: EXPERIMENTAL
Intervention: CleanCook stove and ethanol fuel
Number of subjects: 324
Study 34187482 — intervention group
Group type: COMPARATOR
Intervention: Firewood/kerosene (control group)
Number of subjects: 324
Study 35318290 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implants (Group I)
Number of subjects: 84
Study 35318290 — intervention group
Group type: COMPARATOR
Intervention: Delayed implants (Group II)
Number of subjects: 84
Study 35150446 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU)
Number of subjects: 31
Study 35150446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 34523115 — intervention group
Group type: EXPERIMENTAL
Intervention: P2Y12 inhibitor monotherapy (mostly clopidogrel) following 12 months of DAPT
Number of subjects: 498
Study 34523115 — intervention group
Group type: COMPARATOR
Intervention: Complex PCI
Number of subjects: 498
Study 33636517 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with PTSD
Number of subjects: 542
Study 33636517 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with depressive symptoms
Number of subjects: 542
Study 33636517 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mental health outcomes
Number of subjects: 542
Study 33636517 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of stigma and financial distress
Number of subjects: 542
Study 33636517 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential interventions
Number of subjects: 542
Study 35357957 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous Telehealth Yoga
Number of subjects: 200
Study 35357957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Group Therapies
Number of subjects: 200
Study 35357957 — intervention group
Group type: COMPARATOR
Intervention: Control Group (not specified)
Number of subjects: 200
Study 33801295 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-triggered robotic rehabilitation device treatment
Number of subjects: 60
Study 33801295 — intervention group
Group type: COMPARATOR
Intervention: Lower limb rotor exercises (Control)
Number of subjects: 60
Study 32702848 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 74
Study 32702848 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (group R)
Number of subjects: 74
Study 35863995 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB) with continuous infusion of bupivacaine 0.1% at 7 mL/h for 24 hours
Number of subjects: 35
Study 35863995 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group M) received intravenous morphine patient controlled analgesia for 24 hours
Number of subjects: 35
Study 35863995 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Number of subjects: 35
Study 32649388 — intervention group
Group type: EXPERIMENTAL
Intervention: Lid hygiene
Number of subjects: 42
Study 32649388 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily disposable contact lens (DDCL) fitting (delefilcon A)
Number of subjects: 42
Study 32649388 — intervention group
Group type: COMPARATOR
Intervention: Artificial tear (Povidone‐2%) supplementation
Number of subjects: 42
Study 34543425 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2,000 International Units per day)
Number of subjects: 161
Study 33199752 — intervention group
Group type: EXPERIMENTAL
Intervention: PM-EE 600 mg/day
Number of subjects: 63
Study 33199752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 34363528 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 371
Study 34363528 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 371
Study 34363528 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 371
Study 32872000 — intervention group
Group type: EXPERIMENTAL
Intervention: Goreisan (7.5 g/d for 12 weeks)
Number of subjects: 0
Study 32872000 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (no Kampo medicine)
Number of subjects: 0
Study 34734262 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher egg consumption (4th quartile, equivalent to 5-6 eggs per week)
Number of subjects: 728
Study 34734262 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher egg consumption (4th quartile)
Number of subjects: 728
Study 34734262 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher egg consumption
Number of subjects: 728
Study 33642357 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotaverine (80 mg three times a day, 1 hour before meals)
Number of subjects: 200
Study 33642357 — intervention group
Group type: COMPARATOR
Intervention: Mebeverine (135 mg three times a day, 1 hour before meals)
Number of subjects: 200
Study 32823413 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment (Group B)
Number of subjects: 12
Study 32823413 — intervention group
Group type: COMPARATOR
Intervention: No anti-VEGF treatment (Group A)
Number of subjects: 12
Study 32823413 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF monotherapy
Number of subjects: 12
Study 36031115 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (HD) stimulation
Number of subjects: 12
Study 32776244 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin 0.4 mg once daily for 6 months
Number of subjects: 108
Study 32776244 — intervention group
Group type: COMPARATOR
Intervention: Control group (no α-blockers)
Number of subjects: 108
Study 35073298 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy to hands and feet during chemotherapy
Number of subjects: 48
Study 35073298 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (no cold therapy)
Number of subjects: 48
Study 33853807 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive thoracoscopically guided right minithoracotomy
Number of subjects: 0
Study 33853807 — intervention group
Group type: COMPARATOR
Intervention: Conventional sternotomy
Number of subjects: 0
Study 34590543 — intervention group
Group type: EXPERIMENTAL
Intervention: F(ab’)2AV
Number of subjects: 21
Study 34590543 — intervention group
Group type: COMPARATOR
Intervention: FabAV
Number of subjects: 21
Study 32329198 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied with GaAlAs laser (808 nm, avg. power density: 50 mW, 66 J total dose)
Number of subjects: 44
Study 32329198 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LLLT)
Number of subjects: 44
Study 35993547 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian Time Machine (time-adjusted analyses)
Number of subjects: 0
Study 35993547 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian Time Machine
Number of subjects: 0
Study 35993547 — intervention group
Group type: COMPARATOR
Intervention: Concurrent or pooled controls
Number of subjects: 0
Study 33470693 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP thresholds of ≤60 mmHg
Number of subjects: 1018
Study 33470693 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP thresholds of ≤55 mmHg
Number of subjects: 1018
Study 33470693 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP thresholds of 65 mmHg or above
Number of subjects: 1018
Study 34534138 — intervention group
Group type: EXPERIMENTAL
Intervention: DTG + 3TC
Number of subjects: 1433
Study 34534138 — intervention group
Group type: COMPARATOR
Intervention: DTG + TDF/FTC
Number of subjects: 1433
Study 32789901 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-practice/self-reflection (SP/SR)
Number of subjects: 29
Study 32789901 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behaviour therapy (CBT) book study
Number of subjects: 29
Study 32789901 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behaviour therapy (CBT) training without SP/SR
Number of subjects: 29
Study 33715993 — intervention group
Group type: EXPERIMENTAL
Intervention: Home spirometry with symptom tracking
Number of subjects: 267
Study 33715993 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 267
Study 34016732 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA 6.0 GBq
Number of subjects: 43
Study 34016732 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA 7.4 GBq
Number of subjects: 43
Study 34016732 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole cohort
Number of subjects: 43
Study 34016732 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA decline ≥ 50%
Number of subjects: 43
Study 35341432 — intervention group
Group type: EXPERIMENTAL
Intervention: Controller medications adherence
Number of subjects: 94
Study 35341432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroid bursts
Number of subjects: 94
Study 35341432 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver asthma QoL total score
Number of subjects: 94
Study 35341432 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver asthma QoL activity limitations
Number of subjects: 94
Study 35341432 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver asthma QoL emotional functioning
Number of subjects: 94
Study 35341432 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute healthcare visits
Number of subjects: 94
Study 35341432 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma control
Number of subjects: 94
Study 35291405 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (5 cc of 0.25% solution)
Number of subjects: 74
Study 35291405 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (5 cc of 0.25% solution) plus dexmedetomidine (0.5 µg/kg)
Number of subjects: 74
Study 35291405 — intervention group
Group type: COMPARATOR
Intervention: Control (Ropivacaine only)
Number of subjects: 74
Study 35057479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork dry-cured ham (n = 35)
Number of subjects: 54
Study 35057479 — intervention group
Group type: COMPARATOR
Intervention: Cooked ham (placebo group; n = 19)
Number of subjects: 54
Study 33216756 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving condition (VR visual feedback with a moving virtual hand)
Number of subjects: 30
Study 33216756 — intervention group
Group type: EXPERIMENTAL
Intervention: Hidden condition (no virtual hand)
Number of subjects: 30
Study 33216756 — intervention group
Group type: COMPARATOR
Intervention: Static condition (static virtual hand)
Number of subjects: 30
Study 35963206 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive functional exercise
Number of subjects: 60
Study 35963206 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine treatments)
Number of subjects: 60
Study 32183453 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% Human-animal Interaction (HAI) with Academic Stress Management (ASM) content
Number of subjects: 349
Study 32183453 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% Human-animal Interaction (HAI)
Number of subjects: 349
Study 32183453 — intervention group
Group type: COMPARATOR
Intervention: 0% Human-animal Interaction (HAI) with Academic Stress Management (ASM) content
Number of subjects: 349
Study 32013936 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone ureteral stents (Cook Medical)
Number of subjects: 50
Study 32013936 — intervention group
Group type: COMPARATOR
Intervention: Polyurethane ureteral stents (Rüsch, Teleflex)
Number of subjects: 50
Study 36163982 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on parsaclisib 10 or 20 mg QD for 8 weeks then same dose QW
Number of subjects: 67
Study 36163982 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on parsaclisib 5 or 20 mg QD for 8 weeks then 5 mg QD
Number of subjects: 67
Study 36163982 — intervention group
Group type: COMPARATOR
Intervention: Control group (Ruxolitinib only)
Number of subjects: 67
Study 34728684 — intervention group
Group type: COMPARATOR
Intervention: 2 mA multichannel anodal tDCS (atDCS) over the left dorsolateral prefrontal cortex (lDLPFC)
Number of subjects: 22
Study 34728684 — intervention group
Group type: COMPARATOR
Intervention: 2 mA multichannel anodal tDCS (atDCS) combined with 2-back task
Number of subjects: 22
Study 34728684 — intervention group
Group type: COMPARATOR
Intervention: Control (sham stimulation)
Number of subjects: 22
Study 33586664 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Inspiration Breath-Hold (DIBH)
Number of subjects: 50
Study 33586664 — intervention group
Group type: COMPARATOR
Intervention: Free-Breathing (FB)
Number of subjects: 50
Study 35512402 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab added to adjuvant chemotherapy plus trastuzumab
Number of subjects: 4804
Study 35512402 — intervention group
Group type: COMPARATOR
Intervention: Control group (adjuvant chemotherapy plus trastuzumab without pertuzumab)
Number of subjects: 4804
Study 33340181 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 570
Study 33340181 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine-naloxone (BUP-NX)
Number of subjects: 570
Study 35837711 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab 140 mg every 2 weeks for 2 to 6 weeks before PCI
Number of subjects: 100
Study 35837711 — intervention group
Group type: COMPARATOR
Intervention: Control group (no evolocumab)
Number of subjects: 100
Study 35837711 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab group
Number of subjects: 100
Study 35837711 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 32000470 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical cognitive impairment (PreCI)
Number of subjects: 934
Study 32000470 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical cognitive impairment (PreCI) and postoperative delirium (POD)
Number of subjects: 934
Study 32000470 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnestic presurgical cognitive impairment (PreCI)
Number of subjects: 934
Study 35226723 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab (300 mg subcutaneous, 6 monthly treatments)
Number of subjects: 49
Study 35226723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 33128206 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) plus TCM formula (TGYP and TGJPJD)
Number of subjects: 596
Study 33128206 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (ETV) plus TCM placebo
Number of subjects: 596
Study 33128206 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 596
Study 34933219 — intervention group
Group type: EXPERIMENTAL
Intervention: Action-Based Cognitive Remediation (ABCR)
Number of subjects: 45
Study 34933219 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 34127008 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based enhanced knee flexion exercise program (KFEH)
Number of subjects: 119
Study 34127008 — intervention group
Group type: COMPARATOR
Intervention: Standard supervised physiotherapy (SPT)
Number of subjects: 119
Study 33198514 — intervention group
Group type: EXPERIMENTAL
Intervention: Bodyweight-based strength training (BWST)
Number of subjects: 11
Study 33198514 — intervention group
Group type: COMPARATOR
Intervention: Control session (CS)
Number of subjects: 11
Study 32322048 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rice-based diet (BRD)
Number of subjects: 39
Study 32322048 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat-based diet (WD)
Number of subjects: 39
Study 32322048 — intervention group
Group type: COMPARATOR
Intervention: White rice-based diet (WRD)
Number of subjects: 39
Study 35899310 — intervention group
Group type: EXPERIMENTAL
Intervention: HLX02
Number of subjects: 0
Study 35899310 — intervention group
Group type: COMPARATOR
Intervention: trastuzumab
Number of subjects: 0
Study 33792896 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% glycopyrronium bromide cream applied for 4 weeks
Number of subjects: 0
Study 33792896 — intervention group
Group type: COMPARATOR
Intervention: 0.5%, 1%, and 2% glycopyrronium bromide cream applied topically for 2 weeks
Number of subjects: 0
Study 32146225 — intervention group
Group type: EXPERIMENTAL
Intervention: Phrases with unpleasant connotation (n = 60)
Number of subjects: 120
Study 32146225 — intervention group
Group type: COMPARATOR
Intervention: Objective phrases (n = 60)
Number of subjects: 120
Study 36351733 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 334
Study 36351733 — intervention group
Group type: COMPARATOR
Intervention: Staples or sutures (Control)
Number of subjects: 334
Study 34097448 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL function markers (cholesterol efflux capacity)
Number of subjects: 0
Study 34097448 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel HDL markers
Number of subjects: 0
Study 34097448 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutics targeting HDL metabolism
Number of subjects: 0
Study 32094219 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic cost group (GP stated the weekly monetary cost)
Number of subjects: 60
Study 32094219 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost comparison group (GP compared weekly cost to an everyday discretionary item)
Number of subjects: 60
Study 32094219 — intervention group
Group type: COMPARATOR
Intervention: NHS-funded programme (previous study for comparison)
Number of subjects: 60
Study 32094219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention helpfulness
Number of subjects: 60
Study 32094219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention appropriateness
Number of subjects: 60
Study 32094219 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at weight loss programme
Number of subjects: 60
Study 34495439 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composite (2)
Number of subjects: 76
Study 34495439 — intervention group
Group type: EXPERIMENTAL
Intervention: Bundled fiber post and resin composite (3)
Number of subjects: 76
Study 34495439 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical fiber post and resin composite (4)
Number of subjects: 76
Study 34495439 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal fiber post and resin composite (5)
Number of subjects: 76
Study 34495439 — intervention group
Group type: EXPERIMENTAL
Intervention: Woven fiber post and resin composite (6)
Number of subjects: 76
Study 34495439 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite endocrown (7)
Number of subjects: 76
Study 34495439 — intervention group
Group type: COMPARATOR
Intervention: Control group (1)
Number of subjects: 76
Study 32068354 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-986184 (150 mg subcutaneously every other week)
Number of subjects: 0
Study 32068354 — intervention group
Group type: EXPERIMENTAL
Intervention: Model predictions
Number of subjects: 0
Study 32068354 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic simulations
Number of subjects: 0
Study 37661535 — intervention group
Group type: EXPERIMENTAL
Intervention: Havisure™ vaccine
Number of subjects: 528
Study 37661535 — intervention group
Group type: COMPARATOR
Intervention: Havrix® vaccine
Number of subjects: 528
Study 34187856 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention designed to reduce total fat intake to 20% of energy and to increase vegetable, fruit, and grain consumption (n = 19,541)
Number of subjects: 48835
Study 34187856 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (n = 29,294)
Number of subjects: 48835
Study 32639235 — intervention group
Group type: EXPERIMENTAL
Intervention: RHB-102 (12 mg daily)
Number of subjects: 100
Study 32639235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35983579 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 22616
Study 35983579 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid justification
Number of subjects: 22616
Study 35983579 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician comparison
Number of subjects: 22616
Study 35983579 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid justification and clinician comparison
Number of subjects: 22616
Study 34482041 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm handoff intervention (female twelve-step volunteer met with each woman individually in jail and attended the first twelve-step meeting with her after release)
Number of subjects: 189
Study 34482041 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard care (a list of meetings and community resources)
Number of subjects: 189
Study 34482041 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm handoff intervention
Number of subjects: 189
Study 35081599 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative management (rib fixation)
Number of subjects: 124
Study 35081599 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative management
Number of subjects: 124
Study 34166447 — intervention group
Group type: EXPERIMENTAL
Intervention: MOGBA intervention (14 games-based activities delivered over 9 weeks)
Number of subjects: 904
Study 34166447 — intervention group
Group type: EXPERIMENTAL
Intervention: MOGBA intervention
Number of subjects: 904
Study 33371160 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 0
Study 33371160 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 0
Study 35590399 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral high-definition transcranial random noise stimulation (HD-tRNS) combined with acoustic stimulation (AS)
Number of subjects: 0
Study 35590399 — intervention group
Group type: COMPARATOR
Intervention: Active HD-tRNS
Number of subjects: 0
Study 35590399 — intervention group
Group type: COMPARATOR
Intervention: HD-tRNS alone
Number of subjects: 0
Study 35590399 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroencephalography (EEG) measurements
Number of subjects: 0
Study 35590399 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized questionnaires
Number of subjects: 0